Sjogren's syndrome Trials in Beijing, China
Conditions / Sjogren's syndrome / Beijing, China
Sjogren's syndrome has been the subject of sustained clinical investigation across multiple research sites.
12 total trials for this combination
Showing top 10 of 12 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03023592 | Study of Iguratimod in Sjögren's Syndrome | UNKNOWN | PHASE1/PHASE2 |
| NCT02370550 | Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome | UNKNOWN | PHASE4 |
| NCT06410833 | Belimumab After Rituximab in Resistant Primary Juvenile SS | RECRUITING | PHASE4 |
| NCT05016297 | Efficacy and Safety of Baricitinib in Sjogren's Syndrome | COMPLETED | PHASE2 |
| NCT05946941 | A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT06428188 | Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases | RECRUITING | PHASE1/PHASE2 |
| NCT07062523 | Analyse of Inflammatory Activity of Sjögren's Syndrome on 68Ga-FAPI PET-CT | RECRUITING | PHASE1/PHASE2 |
| NCT06350110 | Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) | RECRUITING | PHASE1/PHASE2 |
| NCT04916756 | A Prospective Pilot Study to Explore Efficacy and Safety of Baricitinib in Active Primary Sjogren's Syndrome Patients | COMPLETED | PHASE1/PHASE2 |
| NCT07301892 | Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis | RECRUITING | — |